 Use omeprazole patients Zollinger-Ellison syndrome Omeprazole substituted benzimidazole potent inhibitor gastric acid secretion patients Zollinger-Ellison syndrome ZES experience data patients ZES omeprazole control gastric acid hypersecretion past years dose omeprazole individual patients hr split dosage regimen Omeprazole effective patients period months percent patients increase omeprazole dose decrease dose Adverse effects attributable patients cases mild ie rash constipation headache effect omeprazole serum gastrin concentration gastric endocrine cells studies patient multiple endocrine neoplasia type-I syndrome MEN-I series gastric carcinoid omeprazole evidence presence MEN-I se important development gastric carcinoid patients ZES omeprazole safe effective patients ZES patients drug choice management gastric acid hypersecretion assessment long-term risk gastric carcinoid therapy gastrinoma